ResMed | RMD - Aktuelle Verpflichtungen

Aktienkurs
219.85
Täglich Wechseln
0.34 0.15%
Monatlich
-2.85%
Jährlich
-6.80%
Q2 Prognose
215.15




Aktuelle Verpflichtungen Veränderung Datum
Ansell USD 468.9M 53.1M 2025-12
Artivion USD 101.56M 15.72M 2025-12
AtriCure USD 81.52M 3.68M 2025-12
Baxter International USD 2.97B 805M 2025-12
Cochlear AUD 558.9M 43.4M 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
CSL USD 4.61B 207M 2025-12
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.81B 225.7M 2025-12
Fisher Paykel Healthcare NZD 471.3M 29.1M 2025-12
Globus Medical USD 498.5M 32.54M 2025-12
Haemonetics USD 539.87M 8.45M 2025-12
Idexx Laboratories USD 1.15B 103M 2025-12
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
Intuitive Surgical USD 2.51B 3.2M 2026-03
Masimo USD 371.6M 1.9M 2025-12
Medtronic USD 9.5B 440M 2025-12
Philips EUR 7.51B 479M 2025-12
Ramsay Health Care AUD 3.95B 514.2M 2025-12
ResMed USD 1.25B 7.39M 2025-12
Sigma Healthcare AUD 1.7B 1.33B 2025-12
Sonic Healthcare AUD 2.23B 92.84M 2024-12
Steris USD 922.3M 33.4M 2025-12
Teleflex USD 762.03M 11.01M 2025-12
Thermo Fisher Scientific USD 14.62B 568M 2026-03